Consortium working with medical authorities on approval for Covid-19 rapid test

A consortium that includes medical diagnostics company Omega is working with the Medicines and Healthcare products Regulatory Agency (MHRA) to enable approval for its Covid-19 lateral flow antibody test. The Alva-based company is part of the consortium led by AIM-listed Abingdon Health developing the AbC-19 Rapid Test. Abingdon, which is York-based, said that while the UK's Department of Health and Social Care has first refusal of supplies of the test through a contract that runs to 14 February, it is also working on potential international distribution. The UK Rapid Test Consortium liaising with customers and regulatory authorities across a total of 27 international territories, to allow future use of the product outside of the UK.